Abstract
Comprehensive genomic profiling (CGP) has become the cornerstone of personalised oncology treatment. Therapeutic approaches based distinctively to patients’ demographics, prior treatment and genomic profiles are now being investigated in clinical trials. Access to suitable trials have also shown to improve outcome. Current trial subject recruitment process is hampered by manual examination of eligibility criteria. An automated decision support system coupled with CGP may help increase clinical trials recruitment and reduce screen failure rates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
